Trial Profile
A retrospective, multicenter study of simeprevir and sofosbuvir with or without ribavirin in liver transplant patients with hepatitis C virus genotype 1 and 4 infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2016 New trial record
- 01 Nov 2016 Results published in the Transplantation Proceedings.